论文部分内容阅读
目的对比泮托拉唑与兰索拉唑治疗幽门螺旋杆菌感染活动性胃溃疡的成本—效果。方法将180例幽门螺旋杆菌感染活动性胃溃疡患者依据随机数字表法分为A组和B组各90例,A组给予泮托拉唑联合克拉霉素片、阿莫西林胶囊治疗,B组给予兰索拉唑联合克拉霉素片、阿莫西林胶囊治疗,对比分析2组临床疗效和成本—效果差异。结果 2组临床疗效比较差异无统计学意义(P>0.05)。A组患者治疗经济学成本—效果优于B组,差异有统计学意义(P<0.05)。结论幽门螺旋杆菌感染活动性胃溃疡患者采取泮托拉唑进行治疗不仅临床效果显著,而且其成本—效果明显优于兰索拉唑治疗方案,值得推广。
Objective To compare the cost-effectiveness of pantoprazole and lansoprazole in the treatment of H.pylori infection in patients with active gastric ulcer. Methods One hundred and eighty patients with active gastric ulcer with Helicobacter pylori infection were divided into group A and group B according to the random number table. Group A received pantoprazole combined with clarithromycin, amoxicillin and group B Lansoprazole combined with clarithromycin tablets, amoxicillin capsules treatment, comparative analysis of two groups of clinical efficacy and cost-effectiveness differences. Results There was no significant difference in clinical efficacy between the two groups (P> 0.05). The cost-effectiveness of treatment in group A was better than that in group B, the difference was statistically significant (P <0.05). Conclusion The treatment of pantoprazole in patients with active gastric ulcer with Helicobacter pylori infection is not only clinically effective, but also cost-effective than lansoprazole treatment program, worthy of promotion.